Clinical Trial Update: Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)

View source ↗

Summary

This update describes a clinical trial evaluating potential gadolinium accumulation from two MRI contrast agents, Dotarem and Multihance, in individuals with mu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• DOTAREM (Gadoterate meglumine)
• MULTIHANCE (Gadobenate dimeglumine)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Multiple Sclerosis | Status: UNKNOWN